Inhibikase Therapeutics, Inc. (IKT)

NASDAQ: IKT · Real-Time Price · USD

1.880

-0.010 (-0.53%)

At close: Mar 6, 2026, 4:00 PM EST

1.900

+0.020 (1.06%)

After-hours: Mar 6, 2026, 6:42 PM EST

Inhibikase Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	38.27	56.49	9.17	7.19	40.75	13.95
Short-Term Investments	39.05	41.05	4.09	15.86	-	-
Cash & Short-Term Investments	77.32	97.54	13.25	23.05	40.75	13.95
Cash Growth	2283.81%	636.06%	-42.51%	-43.44%	192.04%	75500.11%
Accounts Receivable	-	-	-	0.04	0.11	-
Other Current Assets	1.21	0.91	0.96	1.28	1.61	0.83
Total Current Assets	78.54	98.45	14.21	24.37	42.47	14.78
Net Property, Plant & Equipment	-	0.15	0.3	0.57	-	-
Other Long-Term Assets	1.06	-	-	-	-	-
Total Assets	79.59	98.6	14.51	24.94	42.47	14.78
Accounts Payable	0.62	0.94	0.65	1.15	1.09	1.72
Accrued Expenses	3.66	2.68	2.26	2.4	2.72	0.63
Short-Term Debt	-	-	0.38	-	0.25	0.04
Current Portion of Leases	-	0.11	0.15	0.15	-	-
Unearned Revenue	-	-	-	-	-	2.33
Other Current Liabilities	2.42	-	-	-	-	-
Total Current Liabilities	6.7	3.73	3.44	3.7	4.05	4.72
Long-Term Debt	-	-	-	-	-	0.28
Long-Term Leases	-	-	0.09	0.21	-	-
Total Long-Term Liabilities	-	-	0.09	0.21	-	0.28
Total Liabilities	6.7	3.73	3.53	3.9	4.05	5
Common Stock	0.07	0.07	0.01	0	0.03	0.01
Additional Paid-in Capital	202.77	189.25	77.87	68.8	68.21	24.81
Accumulated Other Comprehensive Income	-0	-0.04	0	0.1	-	-
Retained Earnings	-129.95	-94.42	-66.9	-47.87	-29.82	-15.03
Shareholders' Equity	72.9	94.87	10.98	21.04	38.42	9.78
Total Liabilities & Equity	79.59	98.6	14.51	24.94	42.47	14.78
Total Debt	-	0.11	0.62	0.35	0.25	0.32
Net Cash (Debt)	77.32	97.43	12.63	22.7	40.5	13.63
Net Cash Growth	-20.64%	671.44%	-44.36%	-43.95%	197.05%	-
Net Cash Per Share	0.91	4.11	2.10	5.38	13.35	9.96
Book Value	72.9	94.87	10.98	21.04	38.42	9.78
Book Value Per Share	0.85	4.00	1.82	4.98	12.66	7.15
Tangible Book Value	72.9	94.87	10.98	21.04	38.42	9.78
Tangible Book Value Per Share	0.85	4.00	1.82	4.98	12.66	7.15

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q